Drug Database
Back to search

Denmark· DK-28106586521

Axhidrox

A glycopyrronium product containing glycopyrroniumbromid, registered in Denmark by Dr. August Wolff GmbH & Co. KG Arzneimittel. The same ATC class is registered in 14 of our 19 countries.

ATC D11AA01

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedAxhidroxATCD11AA01REGISTER NO.DK-28106586521PACKS LISTED1CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about glycopyrroniumbromidAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Glycopyrronium is registered in 14 of 19 countries.

Countries holding a registration under ATC D11AA01 (glycopyrronium), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 8 of them publish a price we can compare per daily dose
Search glycopyrronium products by name

Glycopyrronium · ATC D11AA01

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
GLYCOPYRRONIUMBROMID
Manufacturer
Dr. August Wolff GmbH & Co. KG Arzneimittel
Country
Denmark (DK)
ATC code
D11AA01
ATC class
Glycopyrronium
Defined daily dose
8.8 mg, T
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28106586521

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

108 interactions on record for glycopyrronium.

Graded by severity as the source publishes them — 107 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check glycopyrronium against other medicinesHow interaction checks work

Glycopyrronium · interactions on record

108 records

  • 107 moderate
  • 1 minor

Most severe, free to view

  • DicycloverineA03AA07moderate
  • PropanthelineA03AB05moderate
  • MepenzolateA03AB12moderate
  • TrospiumA03AB20moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under D11AA01

Glycopyrronium, as other registers publish it.

All glycopyrronium products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/be2652fe-af37-4781-9f5c-609bc29030ab
GET /v1/drugs/be2652fe-af37-4781-9f5c-609bc29030ab?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "creme",
  "source": "dkma",
  "strength": "2,2 mg/dosis",
  "auth_role": "CMS",
  "dk_drugid": "28106586521",
  "substance": "GLYCOPYRRONIUMBROMID",
  "auth_procedure": "Decentral procedure",
  "in_medicinpriser": true,
  "registration_date_serial": "44662"
}
API referenceMCP serverPlans

See everything about glycopyrronium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console